𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rheumatoid arthritis risk allele PTPRC is also associated with response to anti–tumor necrosis factor α therapy

✍ Scribed by Jing Cui; Saedis Saevarsdottir; Brian Thomson; Leonid Padyukov; Annette H. M. van der Helm-Van Mil; Joanne Nititham; Laura B. Hughes; Niek de Vries; Soumya Raychaudhuri; Lars Alfredsson; Johan Askling; Sara Wedrén; Bo Ding; Candace Guiducci; Gert Jan Wolbink; J. Bart A. Crusius; Irene E. van der Horst-Bruinsma; Marieke Herenius; Michael E. Weinblatt; Nancy A. Shadick; Jane Worthington; Franak Batliwalla; Marlena Kern; Ann W. Morgan; Anthony G. Wilson; John D. Isaacs; Kimme Hyrich; Michael F. Seldin; Larry W. Moreland; Timothy W. Behrens; Cornelia F. Allaart; Lindsey A. Criswell; Tom W. J. Huizinga; Paul P. Tak; S. Louis Bridges Jr.; Rene E. M. Toes; Anne Barton; Lars Klareskog; Peter K. Gregersen; Elizabeth W. Karlson; Robert M. Plenge

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
237 KB
Volume
62
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Replication of association of the PTPRC
Replication of association of the PTPRC gene with response to anti–tumor necrosis factor therapy in a large UK cohort
✍ Darren Plant; Rita Prajapati; Kimme L. Hyrich; Ann W. Morgan; Anthony G. Wilson; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Objective Several rheumatoid arthritis (RA) susceptibility variants map close to genes involved in the tumor necrosis factor (TNF) signaling pathway, prompting the investigation of RA susceptibility variants in studies of predictors of response to TNF blockade. Based on a previously reported ass

Anti–tumor necrosis factor α therapy and
Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif